Weihua Zeng Selected Research

Weihua Zeng Research Topics

7	Neoplasms (Cancer) 05/2024 - 09/2007
5	Aplastic Anemia (Anemia, Hypoplastic) 01/2006 - 05/2002
3	Bone Marrow Failure Disorders 01/2006 - 08/2002
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2006 - 05/2002
1	Adenocarcinoma 01/2022
1	Residual Neoplasm 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	De Lange Syndrome (Cornelia De Lange Syndrome) 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2014
1	Colonic Neoplasms (Colon Cancer) 04/2013
1	Lung Neoplasms (Lung Cancer) 05/2008
1	Multiple Myeloma 09/2007
1	Hypersensitivity (Allergy) 04/2007
1	monosomy Chromosome 7 12/2004
1	Genomic Instability 05/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2002
1	Infections 08/2002
1	Large Granular Lymphocytic Leukemia 08/2002

4	Cell-Free Nucleic AcidsIBA 05/2024 - 01/2021
4	AntigensIBA 07/2004 - 07/2002
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2004 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 04/2013 - 07/2002
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CohesinsIBA 01/2017
1	CateninsIBA 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2012
1	Protein CIBA 05/2008
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 05/2008
1	Proteasome InhibitorsIBA 09/2007
1	Antineoplastic Agents (Antineoplastics)IBA 09/2007
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2007
1	Interferon-gamma (Interferon, gamma)IBA 01/2006
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 05/2004
1	fas Receptor (CD95 Antigen)IBA 07/2002
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2002

1	Radiotherapy 01/2022
1	Adjuvant Radiotherapy 01/2022
1	Immunotherapy 01/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 05/2014
1	Therapeutics 12/2004